News
President Trump said companies will pay double for computer chips unless they build in the U.S. Apple secured an exemption ...
Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...
The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.
Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...
10h
Medpage Today on MSNWhen Is CPAP Associated With Cardiovascular Benefit ... vs Harm?
In a pooled analysis of three randomized trials, CPAP had overall null cardiovascular effects in patients with obstructive ...
Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...
Eli Lilly offers an annual dividend yield of 0.78%. So, how can investors exploit its dividend yield to pocket a regular $500 ...
Eli Lilly (LLY) reports Q2 earnings on Aug 7, with booming diabetes and weight-loss drug sales driving strong growth.
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...
When Eli Lilly reports its financial results early Thursday, investors will be looking for the company to press its advantage ...
The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.
10h
TipRanks on MSNEli Lilly’s New ALS Study: A Potential Game-Changer for Investors?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results